71 related articles for article (PubMed ID: 3460477)
21. The utility of interphase fluorescence in situ hybridization for the detection of the translocation t(11;14)(q13;q32) in the diagnosis of mantle cell lymphoma on fine-needle aspiration specimens.
Caraway NP; Gu J; Lin P; Romaguera JE; Glassman A; Katz R
Cancer; 2005 Apr; 105(2):110-8. PubMed ID: 15712276
[TBL] [Abstract][Full Text] [Related]
22. Non-Hodgkin's lymphomas: an immunohistochemical and histological study.
Curran RC; Jones EL
J Pathol; 1979 Dec; 129(4):179-90. PubMed ID: 317105
[TBL] [Abstract][Full Text] [Related]
23. Proliferative activity and DNA index do not significantly predict survival in primary central nervous system lymphoma.
Aho R; Haapasalo H; Alanen K; Haltia M; Paetau A; Kalimo H
J Neuropathol Exp Neurol; 1995 Nov; 54(6):826-32. PubMed ID: 7595655
[TBL] [Abstract][Full Text] [Related]
24. Human immunodeficiency virus-related lymphomas: a possible association between tumor proliferation, lack of ploidy anomalies, and immune deficiency.
McDunn SH; Winter JN; Variakojis D; Rademaker AW; Von Roenn JH; Tallman MS; Gordon LI; Bauer KD
J Clin Oncol; 1991 Aug; 9(8):1334-40. PubMed ID: 1677032
[TBL] [Abstract][Full Text] [Related]
25. Cytogenetic studies in malignant lymphomas: a study of 8 cases.
Coutinho V; Bottura C; Falcao RP
Br J Cancer; 1971 Dec; 25(4):789-801. PubMed ID: 4947349
[TBL] [Abstract][Full Text] [Related]
26. Morphologic types of diffuse large-cell lymphoma.
Warnke RA; Strauchen JA; Burke JS; Hoppe RT; Campbell BA; Dorfman RF
Cancer; 1982 Aug; 50(4):690-5. PubMed ID: 7093905
[TBL] [Abstract][Full Text] [Related]
27. Heterogeneity of neoplastic and reactive cell proliferation in non-Hodgkin's lymphomas linked to patient survival.
Ffrench M; Magaud JP; Ffrench P; Berger F; Devaux Y; Duhaut P; Shen N; Coiffier B; Bryon PA
Am J Clin Pathol; 1994 Apr; 101(4):413-20. PubMed ID: 8160629
[TBL] [Abstract][Full Text] [Related]
28. The Rappaport classification of non-Hodgkin's lymphomas: a closer look using other proposed classifications.
Garvin AJ; Simon R; Young RC; DeVita VT; Berard CW
Semin Oncol; 1980 Sep; 7(3):234-43. PubMed ID: 6998002
[TBL] [Abstract][Full Text] [Related]
29. Surface phenotyping, histology and the nature of non-Hodgkin lymphoma in 157 patients.
Habeshaw JA; Catley PF; Stansfeld AG; Brearley RL
Br J Cancer; 1979 Jul; 40(1):11-34. PubMed ID: 314300
[TBL] [Abstract][Full Text] [Related]
30. Flow cytometric detection of mitotic cells using the bromodeoxyuridine/DNA technique in combination with 90 degrees and forward scatter measurements.
Nüsse M; Jülch M; Geido E; Bruno S; Di Vinci A; Giaretti W; Ruoss K
Cytometry; 1989 May; 10(3):312-9. PubMed ID: 2496957
[TBL] [Abstract][Full Text] [Related]
31. Differentiation of chronic lymphocytic leukemia from other "well to intermediate differentiated" lymphoproliferative disorders by the mouse rosette assay.
Hicks MJ; Grogan TM; Fielder K; Spier CM
Diagn Immunol; 1986; 4(1):31-6. PubMed ID: 3456864
[TBL] [Abstract][Full Text] [Related]
32. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
33. Predictability of immunologic phenotype by morphologic criteria in diffuse aggressive non-Hodgkin's lymphomas.
Jaffe ES; Strauchen JA; Berard CW
Am J Clin Pathol; 1982 Jan; 77(1):46-9. PubMed ID: 7055097
[TBL] [Abstract][Full Text] [Related]
34. DNA ploidy patterns and cytokinetics of non-Hodgkin's lymphoma.
Juneja SK; Cooper IA; Hodgson GS; Wolf MM; Ding JC; Ironside PN; Thomas RJ; Parkin JD
J Clin Pathol; 1986 Sep; 39(9):987-92. PubMed ID: 3760241
[TBL] [Abstract][Full Text] [Related]
35. The use of flow cytometry in the diagnosis and biological characterization of the non-Hodgkin's lymphomas.
Shackney SE
Ann N Y Acad Sci; 1986; 468():171-7. PubMed ID: 3488007
[TBL] [Abstract][Full Text] [Related]
36. Diminished expression of CD19 in B-cell lymphomas.
Yang W; Agrawal N; Patel J; Edinger A; Osei E; Thut D; Powers J; Meyerson H
Cytometry B Clin Cytom; 2005 Jan; 63(1):28-35. PubMed ID: 15624204
[TBL] [Abstract][Full Text] [Related]
37. Morphological subclassification of follicular lymphoma: variability of diagnoses among hematopathologists, a collaborative study between the Repository Center and Pathology Panel for Lymphoma Clinical Studies.
Metter GE; Nathwani BN; Burke JS; Winberg CD; Mann RB; Barcos M; Kjeldsberg CR; Whitcomb CC; Dixon DO; Miller TP
J Clin Oncol; 1985 Jan; 3(1):25-38. PubMed ID: 3965631
[TBL] [Abstract][Full Text] [Related]
38. Flow cytometric discrimination of mitotic cells: resolution of M, as well as G1, S, and G2 phase nuclei with mithramycin, propidium iodide, and ethidium bromide after fixation with formaldehyde.
Larsen JK; Munch-Petersen B; Christiansen J; Jørgensen K
Cytometry; 1986 Jan; 7(1):54-63. PubMed ID: 2419056
[TBL] [Abstract][Full Text] [Related]
39. Cytomorphologic spectrum of small lymphocytic lymphoma in patients with an accelerated clinical course.
Shin HJ; Caraway NP; Katz RL
Cancer; 2003 Oct; 99(5):293-300. PubMed ID: 14579296
[TBL] [Abstract][Full Text] [Related]
40. Differential diagnosis between T-cell lymphoma and Hodgkin's disease: the value of mitotic counts and pericapsular infiltration.
Nguyen D; Nathwani BN; Ellison DJ; Hackett C
Hematol Pathol; 1989; 3(2):63-71. PubMed ID: 2789214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
